FlexDirect® offers adaptable direct-to-patient solutions designed to address diverse clinical supply requirements.
Direct-to-patient (DTP) services are becoming increasingly important because they enhance patient access, improve trial efficiency and support decentralized clinical trials. Catalent FlexDirect® is a direct-to-patient clinical supply service designed to make clinical trials more accessible and convenient by facilitating the delivery of clinical supplies directly to patients’ homes, reducing or even eliminating the need for in-person clinical site visits.
Download this content to learn more about:
- The options available to sponsors within FlexDirect® direct-to-patient supply: Site-to-Patient and Pharmacy-to-Patient models
- The advantages of using a direct-to-patient solution and when to consider using it for your study
Offered Free by: Catalent
See All Resources from: Catalent
